Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1982 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.
Invest New Drugs. 2023 Feb;41(1):122-133. doi: 10.1007/s10637-023-01328-9. Epub 2023 Jan 13.
Invest New Drugs. 2023.
PMID: 36637703
Free PMC article.
Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study.
Ogiwara T, Kawazoe H, Egami S, Hashimoto H, Saito Y, Sakiyama N, Ohe Y, Yamaguchi M, Furukawa T, Hara A, Hiraga Y, Jibiki A, Yokoyama Y, Suzuki S, Nakamura T.
Ogiwara T, et al.
Front Oncol. 2021 Nov 8;11:770268. doi: 10.3389/fonc.2021.770268. eCollection 2021.
Front Oncol. 2021.
PMID: 34820333
Free PMC article.
Item in Clipboard
Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
Demura R, Suda T, Wakabayashi I, Ono M, Jibiki K, Odagiri E, Demura H, Shizume K.
Demura R, et al.
Tohoku J Exp Med. 1982 Jul;137(3):283-7. doi: 10.1620/tjem.137.283.
Tohoku J Exp Med. 1982.
PMID: 6810504
Free article.
Item in Clipboard
Cite
Cite